Chemists discover new signatures to identify cystic fibrosis in infants sooner
Credit: JD Howell, McMaster University Scientists at McMaster University have discovered several new biomarkers from a single drop of blood ...
Tag: Medicine/Health
Yale Cancer Center scientists advise caution in immunotherapy research
New Haven, Conn. -- In a new study, Yale Cancer Center (YCC) scientists suggest that as the number of clinical ...
NIH-developed test detects protein associated with Alzheimer's and CTE
Findings could lead to early diagnosis, better treatment studiesCredit: NIAID WHAT: An ultrasensitive test has been developed that detects a ...
Researchers from the CNIO and the Hospital 12 de Octubre make sense out of the chaos of melanoma
Credit: CNIO Unlike other skin cancers - and without knowing really why - melanoma is one of the most aggressive ...
Age is more than just a number: Machine learning may predict if you're in for a healthy old age
Salk researchers analyze skin cells from more than 100 people of different ages to find molecular signatures that change as ...
Pay-it-forward model increases STD testing among gay men in China
Intervention could be used to increase screening for other infectious diseasesCredit: Jon Gardiner/UNC Chapel-Hill Chapel Hill, N.C. - Chinese gay ...
The production of Ac-225
This article by Dr. Jonathan W. Engle is published in Current Radiopharmaceuticals, Volume 11, Issue 3, 2018Credit: Bentham Science Publisher, ...
Genome offers clues to esophageal cancer disparity
A genomic duplication may help explain why esophageal adenocarcinoma is much more common in Caucasians and presents a potential target ...
Parkinson's disease experts devise a roadmap
Issued in conjunction with the Michael J. Fox Foundation, important consensus guidelines for running proof of concept preclinical and clinical ...
Funding for the development of new gene therapies for cardiovascular diseases
Faculty of Medicine and UKSH Kiel receive 1.4 million euros research funding from the EUCredit: © private Within the framework ...
Current concepts and perspectives on connexin43: A mini review
This article by Dr. Baozhong Shen et al. is published in Current Protein & Peptide Science, Volume 19, Issue 11, ...
Central role of transforming growth factor type beta 1 in skeletal muscle dysfunctions
This article by Dr. Claudio Cabello-Verrugio et al. is published in Current Protein & Peptide Science, Volume 19, Issue 12, ...
Time to biochemical failure could be used as surrogate endpoint in treatment: LA prostate cancer
An analysis of the NRG Oncology clinical trial NRG-RTOG 9202 showed that the interval of time to biochemical failure (IBF), ...
Researchers study epigenetic reprogramming in HIV-associated heart disease
A team from GW is investigating the causes of cardiovascular disease in HIV-infected patients WASHINGTON (Dec. 20, 2018) -- Atherosclerosis ...
Chemotherapeutic drugs and plasma proteins: Exploring new dimensions
This article by Dr. Fahim Halim Khan et al. is published in Current Protein & Peptide Science, Volume 19, Issue ...
A new way to cut the power of tumors
An international group of researchers managed to control the vascularization of tumors by acting on a gene that is overexpressed ...
Threat of 'nightmare bacteria' exhibiting resistance to last-resort antibiotic colistin
Wide dissemination of colistin-resistant Escherichia coli, a growing therapeutic concern, in rural communities in Vietnam revealedCredit: Osaka University A team ...
Higher radiation dose needed to X-ray obese patients increases cancer risk
Extremely obese people are needing a far higher dose of radiation during x-ray examinations than people of normal weight, increasing ...
Nebraska virologists discover safer potential Zika vaccine
New mechanism could be 'huge leap' for immunologyCredit: Craig Chandler | University of Nebraska-Lincoln University of Nebraska-Lincoln researchers may have ...
Targeted treatment slows progression of rare connective tissue tumor
In a phase three clinical trial, sorafenib stopped progression of desmoid tumors for two years in 80 percent of patients ...